Akèy › Maladi mwèl zo
Etid klinik pou Maladi mwèl zo ap rekrite nan Etazini
6 etid pou Maladi mwèl zo ap rekrite patisipan nan sit atravè Etazini.
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Ap rekriteFaz 1/2
Laj 12 a 120 · Tout sèks · Mizajou Sep 30, 2026 · NCT06303193Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07216443Therapeutic RSK1 Targeting in Myelofibrosis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT07379125Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2025 · NCT05423691Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Nov 15, 2024 · NCT06034275The International PNH Interest Group PNH Registry
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 29, 2024 · NCT06524726Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.